MNKD
NASDAQ
US
MannKind Corporation - Common Stock
$2,50
▼ $-0,04
(-1,57%)
Vol. 3.8M
7
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$1.7B
P/E
60,5
ROE
-297,7%
Margine
9,2%
D/E
994,86
Beta
0,86
52W
$3–$7
Consenso Wall Street
15 analisti · Apr 20265
Acquisto forte
8
Compra
2
Mantieni
0
Vendi
0
Vendita forte
86,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
SANA
Sana Biotechnology Inc
$1.1B
SPRY
ARS Pharmaceuticals Inc
$1.2B
ANNX
Annexon Inc
$726.5M
JBIO
Jade Biosciences Inc
$709.8M
KURA
Kura Oncology Inc
$904.1M
VOR
Vor Biopharma Inc
$286.6M
SLS
Sellas Life Sciences Group Inc
$537.0M
MGTX
MeiraGTx Holdings PLC
$639.9M
SLDB
Solid Biosciences Inc
$439.4M
Utili
Tasso di battuta: 25,0%
Prossimo report
Mag 06, 2026
Stima EPS: $0,00
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $0,00 | — | — |
| Dic 2025 | $0,01 | $-0,05 | $-0,06 |
| Set 2025 | $0,02 | $0,07 | +$0,05 |
| Giu 2025 | $0,05 | $0,00 | $-0,05 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -297.7% | -297.7% | -297.7% | -297.7% | -297.7% |
| P/E (TTM) | 35.17 | 37.64 | 52.02 | 53.07 | 59.69 | 60.55 |
| Net Margin | 0.9% | 10.7% | 10.7% | 10.7% | 9.2% | 9.2% |
| Gross Margin | 79.1% | 77.4% | 77.4% | 77.4% | 78.5% | 78.5% |
| D/E Ratio | — | 994.86 | 994.86 | 994.86 | 994.86 | 994.86 |
| Current Ratio | 2.50 | 2.50 | 2.50 | 2.50 | 3.29 | 3.29 |
Rapporti chiave
ROA (TTM)
6,7%
P/S (TTM)
5,55
P/B
4,0
EPS (TTM)
$0,09
CF/Share
$-0,09
Crescita ricavi 3A
+55,9%
52W High
$7,02
52W Low
$3,38
$3,38
Intervallo 52 settimane
$7,02
Як MNKD виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка MNKD vs аналоги Biotechnology
P/E
60,6
▲
222%
sopra
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
5,6
▼
57%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
4,0
▲
64%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість MNKD vs аналоги Biotechnology
ROE
-297,7%
▼
342%
sotto
peer
(-67,3%)
vs Peer
vs Settore
Debole
Net margin
9,2%
▲
103%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
78,5%
▼
0%
sotto
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
6,7%
▲
114%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя MNKD vs аналоги Biotechnology
D/E ratio
994,9
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
3,3
▼
26%
sotto
peer
(4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,9
▼
11%
sotto
peer
(1,0)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів MNKD
MNKD
Mediana peer
Industria
MNKD прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio